Sequans (SQNS) Q1 2026 Earnings Transcript

Sequans reported Q1 revenue of $6.1 million, down from $6.9 million last quarter, with gross margin at 37.7% and a non-IFRS net loss of $20.7 million as Bitcoin-related charges continued to distort results. Management guided Q2 revenue to $6.8 million-$7.4 million and said it expects a near debt-free balance sheet by June 1 after redeeming the remaining $94.5 million convertible debt using Bitcoin sales. The call also highlighted a $22 million backlog, a $300 million design-win pipeline, and plans to cut cash operating expenses below $10 million by year-end.

Analysis

The core equity story is no longer the Bitcoin treasury experiment; it is a forced de-risking that converts SQNS into a cleaner, earlier-stage operating turnaround with a de facto embedded call option on the remaining coin inventory. That matters because the market can re-rate the stock on a simpler lens: product backlog conversion, gross margin stabilization, and operating leverage into 2H26/2027 rather than perpetual balance-sheet noise. The near-term winner is the common equity if management actually executes the debt wipeout without materially impairing liquidity; the loser is any investor who was underwriting the stock primarily as a levered crypto vehicle.

The second-order effect is on supplier and customer behavior. A near debt-free balance sheet lowers counterparty concern, which should help Sequans close design-ins with larger industrial customers who care about continuity of supply more than headline revenue size. But the memory-cost spike is the hidden margin tax: if demand inflects faster than procurement, incremental revenue can arrive with lower gross margin, muting the operating leverage bulls expect and making 2H upside less clean than the narrative suggests.

The real catalyst window is the next 4-8 weeks around full debt redemption and the 20-F filing, then the June/July cadence of production conversions and any licensing prepayments. The stock could work sharply if management proves that backlog converts into sequential revenue growth while cash burn trends below the current run-rate; conversely, the setup breaks if Cat-1bis ramps slip by even a month or two or if the company needs to monetize Bitcoin faster than planned to preserve working capital. In that case, the market will reprice SQNS back toward a dilutive microcap hardware story rather than an asymmetric turn.

Contrarian view: consensus may be underestimating how much optionality comes from abandoning the treasury strategy. That move removes the left-tail risk that the company becomes hostage to crypto volatility just as the operating business starts to improve. The flip side is that once the Bitcoin thesis is neutralized, the stock must stand on industrial fundamentals alone — which means execution quality over the next two quarters matters more than any longer-dated eRedCap story.

Key Decisions for Investors

• Long SQNS for a 4-8 week catalyst trade into full debt redemption / 20-F filing; size modestly because the upside is driven by de-risking and sentiment reset, while the downside is a return to microcap hardware skepticism.
• Use call spreads rather than outright shares on SQNS if liquidity allows: target the June/July window where balance-sheet clarity and backlog conversion can re-rate the stock; cap downside to time decay if Cat-1bis timing slips.
• Pair trade: long SQNS / short a more crypto-exposed small-cap balance-sheet story, or long SQNS / short speculative hardware peers with weaker funding runway; thesis is that de-risking plus backlog visibility should compress the valuation gap.
• If holding SQNS common, set a hard risk limit into 2H26: trim on any sign that gross margin deteriorates faster than revenue inflects, since memory inflation can convert top-line beats into low-quality growth.
• Watch for licensing-prepayment announcements as a tactical add point; a mid-single-digit million upfront deal would improve the funding mix and likely force a second-leg move in the stock over days, not months.